Incidence of anticoagulation in patients with bioprostheses.
Gherli
Tiziano
T
Cardiac Surgery Department, Università degli Studi di Parma, Italy.
Colli
Andrea
A
Nicolini
Francesco
F
D000925:Anticoagulants / Q000627:therapeutic use*; D001021:Aortic Valve / Q000601:surgery; D001241:Aspirin / Q000627:therapeutic use*; D001705:Bioprosthesis / Q000009:adverse effects*; D005500:Follow-Up Studies; D006349:Heart Valve Diseases / Q000601:surgery; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D020766:Intracranial Embolism / Q000209:etiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011446:Prospective Studies; D016019:Survival Analysis; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D001241:Aspirin